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Cell selection from a murine tumour using the fluorescent
probe Hoechst 33342
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Medical Biophysics Unit, British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, B.C.
V5Z IL3, Canada.
The relatively poor blood supply found in many
solid tumours is thought to result in a population
of cells distant from blood vessels which are
hypoxic and therefore resistant to radiation. They
are also thought to be resistant to many
chemotherapeutic agents because of hypoxia (Hill &
Stanley, 1975; Dixon et al., 1978; Hill, 1979), a
slow proliferation rate (Tannock, 1968) or perhaps
most important, the number of cell layers a drug
must pass through in order to reach them.
Although in vitro experiments with hypoxic and/or
slowly proliferating cells can give much indirect
evidence as to the response of such cells in vivo, it
would be most desirable to directly evaluate the
response of these "location resistant" cells after
treatment in the tumour microenvironment.
A method for separating tumour cells as a
function of their distance from the blood supply
would enable the response of the cells after
treatment to be assessed. Durand (1982) has
recently demonstrated that fluorescence activated
cell sorting using the bisbenzamide stain, Hoechst
33342, can be used to separate cells as a function of
depth within multicell spheroids. We have now
applied this technique to murine tumours in vivo.
The basis for the separation procedure is that the
fluorescent DNA stain Hoechst 33342, as a result
of its high avidity for cellular DNA, exhibits a
marked diffusion/consumption gradient when it has
to pass through several cell layers (Durand, 1982).
This results in a situation where the cells closest to
the drug "reservoir", i.e. media in the case of
multicell spheroids or blood supply in the case of
tumours, become more intensely stained. Indeed
this property has recently been used to investigate
vascular patterns within tumours (Reinhold &
Visser, 1983). In addition to this staining pattern,
Hoechst 33342 possesses several other charac-
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teristics which make it suitable for isolation of cell
sub-populations from tumours in vivo: (i) it shows
only a slow "efflux" from the cell, (ii) it can be
used at concentrations known to possess relatively
low mutagenic and toxic properties in vitro, and (iii)
no additional toxicity has been demonstrated when
the stain is used in conjunction with ultraviolet
laser beams operated at <100mw power (Durand
& Olive, 1982).
The LD50 of Hoechst 33342 after i.v. injection in
C57BL mice is >200pgg-1. In our initial
experiments we have used a dose of 2-10pgg-1
(injected in 0.3ml of sterile saline). Two
fluorescence photomicrographs of frozen sections
obtained from a s.c. implanted Lewis lung tumour
(6-7mm diameter) excised 20min after injection of
Hoechst 33342 (lOggg- IV) are shown in Figure
1. It can be seen that the tumour vasculature is
clearly defined with cells close to vessels being
brightly fluorescent whereas eells distant from
blood vessels have a very low fluorescence intensity.
This indicates that i.v. injection of Hoechst 33342
results in a pattern of cellular fluorescence intensity
inversely related to the distance of the cell from the
vascular network. Since this staining pattern
remains unchanged for several hours post injection
(unpublished results), the distribution of the stain
provides the basis for cell selection as a function of
position within the tumour.
A more quantitative approach to estimating the
distribution of Hoechst 33342 staining within the
tumour can be achieved by analysis of tumour cells
using a dual laser FACS 440. Using this technique,
several distinct sub-populations with widely-varying
sizes (light scatter) and fluorescence intensity can be
resolved (Figure 2). On the basis of this hetero-
geneous stain distribution, cells can be sorted into
sub-groups based on fluorescence intensity and
thus on the basis of their proximity to blood vessels
at the time of injection of the fluorescent stain.
Furthermore, on the basis of the light scatter
signals, we can exclude much of the debris and
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Figure 1 Fluorescence photomicrographs of sections from a 6-7mm subcutaneous Lewis lung carcinoma
excised 20min after IV injection of Hoechst 33342 (1O0gg-1 IV).
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Figure 2 Qualitative example of the cell populations resolved by flow cytometric analysis of forward light
scatter and Hoechst 33342 fluorescence intensity. Though distinct peaks appear for cellular debris, normal
and tumour cells (in line with the increasing forward scatter signal), these populations also overlap
considerably.
some of the normal cell population thus facilitating
isolation of cell sub-populations enriched with
tumour cells.
The cells obtained after sorting can be assayed
for cell survival in vitro using the soft agar
clonogenic assay (Courtenay, 1976). Figure 3 shows
the plating efficiency of cells, obtained from a s.c.
Lewis lung carcinoma, as a function of fluorescence
intensity: Fraction 1 is the brightest 10% of cells,
fraction 2 is the next 10% brightest, etc. It can be
seen that the P.E. is decreased in the brightest and
dimmest 10% of cells; this probably reflects
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Figure 3 Plating efficiency of cells obtained from the
Lewis lung carcinoma as a function of their
fluorescence intensity. Fraction 1 is the brightest 10%
of cells, fraction 2 is the next 10% brightest, etc.
(mean+s.e. of 10 experiments).
"contamination" of the sorted cells by (non-
clonogenic) normal cells in the brightly staining
fractions, and decreased viability of the tumour
cells and increased "contamination" with debris at
greater distances from the vasculature. Though we
could set more exclusive gates with the sorter, we
believe it is more useful to be sure that all tumour
cells are recovered and assayed. By knowing the
P.E. for each fraction in control and treated
tumours, a surviving fraction as a function of
decreasing fluorescence can be obtained. In addition
to the 10 sorted fractions, the 'unsorted' cell
suspension is routinely assessed for clonogenicity
both before and after passage through the FACS.
The results obtained to date indicate that neither
the staining nor laser exposure have any measurable
toxicity on the cell population as a whole.
In our preliminary investigations, we have treated
tumour bearing mice with either adriamycin
(15mgkg-1 i.p.) or lOGy of X-rays. These agents
were chosen because they were expected to give a
differential pattern of toxicity between cells close
and cells distant from blood vessels.
Adriamycin At the adriamycin concentration used
(15mgkg-1) no tumour "response" can be
measured in the Lewis lung carcinoma using
conventional assays. Our selection technique clearly
demonstrates cytotoxicity in the more fluorescent
cells, i.e. those closest to the blood vessels (Figure
4). This would be expected from the diffusion
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Figure 4 Surviving fraction of cells obtained from the
Lewis lung carcinoma, 18h after i.p. injection of
adriamycin (15mgkg-1), as a function of their
fluorescence intensity. Different symbols represent
independent experiments (0) 10 ggg- Hoechst
injected; (A) 2 ggg-1 Hoechst injected.
related problems previously observed with this drug
both in spheroids (Sutherland et al., 1979; Durand,
1982) and tumours (Ozols et al., 1979). It is not
possible to rule out completely the possibility that
at least some of the cytotoxicity seen results from
an interaction between Hoechst 33342 and
adriamycin damage. However, if this was the case,
we might expect that the level and pattern of
cytotoxicity would be dependent, to some extent,
on the dose of Hoechst 33342 injected. It can be
seen in Figure 4 that over a 5-fold range in the
Hoechst 33342 dosage (which translates to a 5-fold
difference in the fluorescence intensity in the
brightest cells) no change in either the level or
pattern ofcytotoxicity can be demonstrated.
X-rays It is known from in vitro and in vivo
studies that hypoxic cells are more resistant to
radiation than are oxic cells. Our Lewis lung
tumour has been shown using conventional assays
to possess an hypoxic fraction of -10% (Chaplin
et al., 1983). As a result of this fact, we expected to
find greater survival in the cells distant from the
blood supply after irradiation. The results we have
obtained after 10Gy of X-rays are shown in Figure
5. It can be seen that indeed, there is an increase in
radioresistance as we move from bright to dim
cells. However, this increase is not as dramatic as
expected from previous work with multicell
spheroids (Durand, 1982). One likely explanation
for this is that acute (transient) hypoxia occurs in572 D.J. CHAPLIN et al.
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Figure 5 Surviving fraction of cells obtained from the
Lewis lung carcinoma, immediately after 1OGy of X-
rays, as a function of their fluorescence intensity
(mean+s.e. of 3 experiments).
the Lewis lung carcinoma in a time frame much
shorter than that for which the cells are exposed to
Hoechst 33342. Alternatively, several other factors
could contribute to the response observed, these
include: (i) a reduction in growth fraction (i.e.
decrease in radioresistance) of the different cell
populations in line with their decreasing
fluorescence, (ii) cells distant from blood vessels
may be situated in a more severe micro-
environment, i.e. low pH, low nutrients etc. which
may decrease radioresistance, or (iii) our sorting
"resolution" decreases with decreasing fluorescence
and thus may not adequately isolate a hypoxic
population as small as 10%.
Although the results presented are preliminary,
the technique described offers the possibility of
monitoring the response of specific tumour sub-
populations after treatment with either radiation or
cytotoxic drugs. In addition, it should enable
assessment of cell kinetic and biochemical
differences between these sub-populations. Such
information will undoubtedly aid in the design of
both new agents and more effective treatment
regimes.
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